IMPROVEMENT OF ADVANCED LIVER FIBROSIS AND REGRESSION OF LIVER CIRRHOSIS IN PATIENTS WITH HEPATITIS C GENOTYPE 1 AFTER HCV PROTEASE INHIBITOR-BASED TRIPLE THERAPY

被引：1
|
作者：
Saez-Royuela, F. [1 ]
Linares, P. [2 ]
Cervera, L. A. [1 ]
Almohalla, C. [3 ]
Jorquera, F. [2 ]
Garcia, I. [4 ]
Moncada, A. [1 ]
Karpman, G. [5 ]
Badia, E. [1 ]
Vallecillo, M. A. A. [3 ]
Lorenzo, S. [6 ]
Olcoz, J. L. [2 ]
机构：
[1] Hosp Univ Burgos, Gastroenterol & Hepatol, Burgos, Spain
[2] Complejo Asistencial Univ Leon, Gastroenterol & Hepatol, Leon, Spain
[3] Hosp Univ Rio Hortega, Hepatol, Valladolid, Spain
[4] Complejo Asistencial Palencia, Gastroenterol & Hepatol, Palencia, Spain
[5] Hosp Bierzo, Gastroenterol & Hepatol, Ponferrada, Spain
[6] Ospital Clin Univ, Gastroenterol & Hepatol, Valladolid, Spain
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30923-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0720
引用
收藏
页码：S594 / S594
页数：1
相关论文
共 50 条
  • [1] Performance of Two HCV RNA Assays during Protease Inhibitor-Based Triple Therapy in Patients with Advanced Liver Fibrosis and Cirrhosis
    Maasoumy, Benjamin
    Hunyady, Bela
    Calvaruso, Vincenza
    Makara, Mihaly
    Vermehren, Johannes
    Haragh, Attila
    Susser, Simone
    Bremer, Birgit
    Cloherty, Gavin
    Manns, Michael P.
    Craxi, Antonio
    Wedemeyer, Heiner
    Sarrazin, Christoph
    [J]. PLOS ONE, 2014, 9 (11):
  • [2] Performance of Cobas Taqman and Abbott Realtime HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosis
    Maasoumy, Benjamin
    Hunyady, Bela
    Calvaruso, Vincenza
    Makara, Michael
    Vermehren, Johannes
    Haragh, Attila
    Susser, Simone
    Bremer, Birgit
    Cloherty, Gavin A.
    Manns, Michael P.
    Craxi, Antonio
    Wedemeyer, Heiner
    Sarrazin, Christoph
    [J]. HEPATOLOGY, 2014, 60 : 906A - 907A
  • [3] Evaluation of advanced fibrosis measured by transient elastography after hepatitis C virus protease inhibitor-based triple therapy
    Saez-Royuela, Federico
    Linares, Pedro
    Cervera, Luis A.
    Almohalla, Carolina
    Jorquera, Francisco
    Lorenzo, Sara
    Garcia, Isidro
    Karpman, Guillermo
    Badia, Ester
    Vallecillo, Maria A.
    Moncada, Adriana
    Calvo, Sara
    Olcoz, Jose L.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (03) : 305 - 312
  • [4] Treatment of Chronic Hepatitis C With Protease Inhibitor-Based Therapy After Liver Transplantation
    Reddy, K. Rajender
    Everson, Gregory T.
    [J]. HEPATOLOGY, 2013, 58 (03) : 1181 - 1184
  • [5] Protease inhibitor-based triple therapy is highly effective in liver transplant recipients with genotype 1 hepatitis C recurrence: A Canadian multicentre experience
    Faisal, Nabiha
    Renner, Eberhard L.
    Bilodeau, Marc
    Yoshida, Eric M.
    Wong, Philip
    Ma, Mang M.
    Burak, Kelly W.
    Al-Judaibi, Bandar
    Cooper, Curtis
    Shaw-Stiffel, Thomas
    Lilly, Les
    [J]. HEPATOLOGY, 2013, 58 : 238A - 238A
  • [6] Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience
    Faisal, Nabiha
    Yoshida, Eric M.
    Bilodeau, Marc
    Wong, Philip
    Ma, Mang
    Burak, Kelly W.
    Al-Judaibi, Bandar
    Renner, Eberhard L.
    Lilly, Leslie B.
    [J]. ANNALS OF HEPATOLOGY, 2014, 13 (05) : 525 - 532
  • [7] Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver
    Leroy, Vincent
    Serfaty, Lawrence
    Bourliere, Marc
    Bronowicki, Jean-Pierre
    Delasalle, Patrick
    Pariente, Alexandre
    Pol, Stanislas
    Zoulim, Fabien
    Pageaux, Georges-Philippe
    [J]. LIVER INTERNATIONAL, 2012, 32 (10) : 1477 - 1492
  • [8] Risk of acute liver injury with protease inhibitor-based antiviral therapy for hepatitis C
    Torgersen, Jessie
    Newcomb, Craig W.
    Carbonari, Dena M.
    Rentsch, Christopher T.
    Park, Lesley S.
    Mehta, Rajni
    D'Addeo, Kathryn
    Taddei, Tamar
    Justice, Amy C.
    Lo Re, Vincent, III
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 614 - 615
  • [9] Outcome of antiviral therapy in Egyptian Hepatitis C Virus (HCV) genotype 4 patients with advanced liver fibrosis
    El Khattib, Ahmed A.
    Abdelhakam, Sara M.
    Ghoraba, Dalia M.
    Ibrahim, Wesam A.
    Sayed, Moataz M.
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (01) : E34 - E35
  • [10] Early Improvement of Liver Stiffness Measured by ARFI During Protease Inhibitor Based Triple Therapy for Chronic Hepatitis C
    Ajimine, Takuma
    Goto, Takashi
    Ohnishi, Hirohide
    Miura, Kouichi
    Ohshima, Shigetoshi
    Shibuya, Tomomi
    Sato, Wataru
    Kanata, Ryo
    Sakai, Toshitaka
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S229 - S229
12345